Shenzhen Geno-immune Medical Institute

This study tests a new treatment called 4SCAR-T cells for people with advanced bladder cancer that has spread and has no other treatment options. The therapy uses a patient's own immune cells, modified in a lab to better recognize and attack cancer cells. The trial aims to see if…

This trial tests a gene therapy for Chronic Granulomatous Disease (CGD), a rare immune disorder that causes severe infections. The therapy uses a modified virus to deliver a working copy of the faulty gene into the patient's bone marrow cells. The goal is to restore immune functi…

This study tests a new treatment called 4SCAR19 for people with B-cell cancers that have come back or not responded to other treatments. The therapy uses a patient's own immune cells, modified to better find and attack cancer cells. The goal is to see if it is safe and effective,…

This study tests a new treatment for people with solid tumors that have not responded to standard therapy. The treatment uses a patient's own immune cells, modified to recognize and attack a protein called GD2 found on many tumor cells. The goal is to control the disease and unde…

This early-stage trial tests a gene therapy for hemophilia B, a bleeding disorder. Doctors take a patient's own stem cells, add a working gene for clotting factor IX, and put them back. The goal is to see if it's safe and helps the body make its own clotting factor, reducing the …